Skip to main content
PODD
NASDAQ Life Sciences

Insulet Slashes US Sales Outlook, Shares Plunge 12%

Tom Rudovsky · Reported by Reuters
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$144.52
Mkt Cap
$11.555B
52W Low
$138.79
52W High
$354.88
52W Position info
4.1% above low
Off High info
59% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

PODD is trading near its 52-week low of $138.79 (4.1% above the low).

Summary

Insulet cut its full-year revenue growth forecast to 20-22% from 21-23%, driven by a sharper slowdown in U.S. Omnipod sales — now seen growing 17-19% vs. prior 20-22%. The revision confirms fears that competition and a maturing type 2 diabetes ramp are eroding growth faster than expected. Q2 results beat on both top and bottom lines, with revenue of $801.7M and adjusted EPS of $1.66, but the guidance cut overshadows the beat. International guidance was raised to 30-32% growth, partially offsetting U.S. weakness. This follows a May device correction and a July securities fraud lawsuit, adding to a negative narrative. The stock, already near 52-week lows, fell over 12% pre-market, signaling deep investor concern about the growth trajectory into 2027.

At the time of this announcement, PODD was trading at $144.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $11.6B. The 52-week trading range was $138.79 to $354.88. This news item was assessed with negative market sentiment and an importance score of 9 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

PODD - Latest Insights

PODD
Nov 04, 2026, 4:05 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $165.02
Real-time Price: $143.96 info
Change: -$21.06 (-13%) info
Market Cap: $9.992B info
PODD
Nov 04, 2026, 2:21 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $162.27
Real-time Price: $143.96 info
Change: -$18.30 (-11%) info
Market Cap: $9.992B info
PODD
Nov 04, 2026, 7:01 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $155.77
Real-time Price: $143.96 info
Change: -$11.81 (-8%) info
Market Cap: $9.992B info
PODD
Nov 04, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $155.77
Real-time Price: $143.96 info
Change: -$11.81 (-8%) info
Market Cap: $9.992B info
PODD
Aug 05, 2026, 7:04 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $147.60
Real-time Price: $143.96 info
Change: -$3.64 (-2%) info
Market Cap: $9.992B info